Literature DB >> 9054131

Lack of virulence of the murine fibroblast adapted strain, Kentucky A (KyA), of equine herpesvirus type 1 (EHV-1) in young horses.

T Matsumura1, D J O'Callaghan, T Kondo, M Kamada.   

Abstract

The virulence of the cell culture adapted KyA strain of equine herpesvirus type 1 (EHV-1), which lacks at least six genes by deletions in its genome, was assessed by intranasal inoculation of six young horses that were serologically negative for EHV-1. No horses showed clinical signs, and a neutralizing antibody response against EHV-1 was detected in two horses which had antibodies against EHV-4 prior to the inoculation. A challenge experiment using a highly virulent strain of EHV-1 conducted 4 weeks later against 4 of the 6 horses inoculated intranasally with the KyA strain and 2 control horses revealed that (i) the KyA inoculated horses were protected from manifestation of clinical signs detected in both control horses, with the exception of pyrexia, (ii) duration of virus isolation from the KyA inoculated horses after the challenge was remarkably shortened as compared to that from control horses; (iii) thus, animals inoculated with the KyA and challenged with pathogenic EHV-1 showed a reduction in the time of virus shedding and viremia; (iv) two horses which exhibited no antibody responses after the KyA inoculation showed antibody responses after the challenge significantly higher than those of control horses. The results reveal that the KyA strain has no virulence but still possesses immunogenicity for horses, suggesting that some of the genes deleted from the KyA strain might have importance in the expression of EHV-1 virulence.

Entities:  

Mesh:

Substances:

Year:  1996        PMID: 9054131     DOI: 10.1016/0378-1135(09)59999-3

Source DB:  PubMed          Journal:  Vet Microbiol        ISSN: 0378-1135            Impact factor:   3.293


  13 in total

1.  Severe murine lung immunopathology elicited by the pathogenic equine herpesvirus 1 strain RacL11 correlates with early production of macrophage inflammatory proteins 1alpha, 1beta, and 2 and tumor necrosis factor alpha.

Authors:  P M Smith; Y Zhang; W D Grafton; S R Jennings; D J O'Callaghan
Journal:  J Virol       Date:  2000-11       Impact factor: 5.103

2.  Immunization with Attenuated Equine Herpesvirus 1 Strain KyA Induces Innate Immune Responses That Protect Mice from Lethal Challenge.

Authors:  Seong K Kim; Akhalesh K Shakya; Dennis J O'Callaghan
Journal:  J Virol       Date:  2016-08-26       Impact factor: 5.103

3.  An Equine Herpesvirus Type 1 (EHV-1) Ab4 Open Reading Frame 2 Deletion Mutant Provides Immunity and Protection from EHV-1 Infection and Disease.

Authors:  Christiane L Schnabel; Susanna Babasyan; Alicia Rollins; Heather Freer; Christine L Wimer; Gillian A Perkins; Fahad Raza; Nikolaus Osterrieder; Bettina Wagner
Journal:  J Virol       Date:  2019-10-29       Impact factor: 5.103

4.  The ICP0 protein of equine herpesvirus 1 is an early protein that independently transactivates expression of all classes of viral promoters.

Authors:  D E Bowles; V R Holden; Y Zhao; D J O'Callaghan
Journal:  J Virol       Date:  1997-07       Impact factor: 5.103

5.  Intranasal treatment with CpG-B oligodeoxynucleotides protects CBA mice from lethal equine herpesvirus 1 challenge by an innate immune response.

Authors:  Seong K Kim; Akhalesh K Shakya; Dennis J O'Callaghan
Journal:  Antiviral Res       Date:  2019-06-25       Impact factor: 5.970

6.  Characterization of the cytolytic T-lymphocyte response to a candidate vaccine strain of equine herpesvirus 1 in CBA mice.

Authors:  P M Smith; Y Zhang; S R Jennings; D J O'Callaghan
Journal:  J Virol       Date:  1998-07       Impact factor: 5.103

7.  The truncated form of glycoprotein gp2 of equine herpesvirus 1 (EHV-1) vaccine strain KyA is not functionally equivalent to full-length gp2 encoded by EHV-1 wild-type strain RacL11.

Authors:  Jens von Einem; Janet Wellington; J Millar Whalley; Kerstin Osterrieder; Dennis J O'Callaghan; Nikolaus Osterrieder
Journal:  J Virol       Date:  2004-03       Impact factor: 5.103

8.  Genomic, Recombinational and Phylogenetic Characterization of Global Feline Herpesvirus 1 Isolates.

Authors:  Andrew C Lewin; Aaron W Kolb; Gillian J McLellan; Ellison Bentley; Kristen A Bernard; Sandra P Newbury; Curtis R Brandt
Journal:  Virology       Date:  2018-03-30       Impact factor: 3.616

9.  Meningoencephalitis in mice infected with an equine herpesvirus 1 strain KyA recombinant expressing glycoprotein I and glycoprotein E.

Authors:  Arthur R Frampton; Patrick M Smith; Yunfei Zhang; Warren D Grafton; Tomio Matsumura; Nikolaus Osterrieder; Dennis J O'Callaghan
Journal:  Virus Genes       Date:  2004-08       Impact factor: 2.332

10.  The UL4 protein of equine herpesvirus 1 is not essential for replication or pathogenesis and inhibits gene expression controlled by viral and heterologous promoters.

Authors:  Robert A Charvat; Jonathan E Breitenbach; ByungChul Ahn; Yunfei Zhang; Dennis J O'Callaghan
Journal:  Virology       Date:  2011-02-15       Impact factor: 3.513

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.